Symposia: Chemical Biology and Experimental Therapeutics
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Sickle Cell Disease, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, Combination therapy, MDS, Iron Deficiency, Translational Research, Plasma Cell Disorders, Genomics, Hemoglobinopathies, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Treatment Considerations, Lymphoid Malignancies, Metabolism, Myeloid Malignancies, Biological Processes, Emerging technologies, Molecular biology, Technology and Procedures, Multi-systemic interactions, Pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Sickle Cell Disease, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, Combination therapy, MDS, Iron Deficiency, Translational Research, Plasma Cell Disorders, Genomics, Hemoglobinopathies, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Treatment Considerations, Lymphoid Malignancies, Metabolism, Myeloid Malignancies, Biological Processes, Emerging technologies, Molecular biology, Technology and Procedures, Multi-systemic interactions, Pathogenesis
Saturday, December 7, 2024: 12:00 PM-1:30 PM
Room 33
(San Diego Convention Center)
Moderators:
Giulia Biancon, PhD, ARRAY(0xf0424dc)
and
Valeria Visconte, PhD, Taussig Cancer Institute
Disclosures:
No relevant conflicts of interest to declare.
12:15 PM
12:30 PM
12:45 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH